Hints and tips:
Related Special Reports
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
...From customer service chatbots to data migration and overhauling research and development in healthcare, Schweizer said BCG is helping companies use AI to cut costs and increase productivity....
...WuXi AppTec, which provides research and development services, earned 66 per cent of its Rmb18.9bn ($2.6bn) in 2023 revenues from the US, according to its annual report released in August....
...Of these, founders from Musicmetric, Emotient, Silk Labs, PullString, CamerAI, Fashwell, Spectral Edge, Inductiv Inc, Vilynx, AI Music and WaveOne all still work at Apple, according to their LinkedIn profiles...
...The company provides the risk scores to the UK’s Our Future Health project, the country’s largest research programme....
...So effective is Vertex Pharmaceuticals’ blockbuster cystic fibrosis (CF) drug, Trikafta, that studies project it could extend the lives of some young patients by up to 45 years....
...The partnership strengthens Sanofi, one of the world’s largest vaccine makers by sales, in the post-pandemic Covid jab market, where pharmaceutical groups are increasingly focused on combined shots against...
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
...The National Institute for Health and Care Excellence announced on Tuesday that it would not approve the medication Enhertu, developed by pharmaceutical companies Daiichi Sankyo and AstraZeneca, to treat...
...Yet while much about long-term effects is still unknown, Zbinksi says commercial clinics offering the drug for an array of conditions are springing up faster than new research....
...Treatments like this come with large upfront research and development costs but, by preventing chronic diseases, could lead to long-term savings: the yearly costs of asthma in the US alone are $56bn, mainly...
...The National Health Service had seen and treated record numbers of cancer patients over the past two years, and one-year survival rates had improved from 65.6 per cent in 2005 to 74.6 per cent in 2020, it...
...The Association of the British Pharmaceutical Industry, the drugmakers’ trade body, said it supported “this tough deal” even though the agreement would continue to restrict pharmaceutical companies’ sales...
...Eli Lilly is racing to secure the services of outsourcers to boost production of its obesity drug Zepbound, as the US pharmaceutical group rolls out its rival to Danish group Novo Nordisk’s blockbuster appetite...
...Pharmaceuticals groups Pfizer and Moderna, which have both faced criticism from fringe groups over their Covid-19 vaccines, also spent heavily on security for their CEOs last year....
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
...Tom Bailey, head of research at HANetf, issuer of the second-largest defence ETF, the Future of Defence Ucits ETF (NATO), said flows were being driven by two main factors....
...“You can be in passive, you can be in ETFs, and you can be in both,” said Ryan Jackson, a manager research analyst with Morningstar. “You don’t have to sell both, but you can’t sell neither.”...
...Rival pharmaceutical groups are eager to enter the market, including AstraZeneca, which recently signed a licensing deal with Chinese company Eccogene for the rights to its weight loss pill....
...Biotech is one of the most promising areas of future economic growth, combining research, high-tech manufacturing and service sector work. As the IMF declared: “vaccine policy is economic policy.”...
...New York-based Visible Alpha pools together investment research and financial models by sellside investment banks into aggregated data for asset managers....
...The research showed substantial variation between the types of cancer....
...*Ignites Europe is a news service published by FT Specialist for professionals working in the asset management industry. Trials and subscriptions are available at igniteseurope.com....
...Research on the topic has demonstrated corporate governance is not a priority concern for companies choosing a listing jurisdiction....
...The research is the latest effort to use cutting-edge computing techniques to boost the fight against cancer, which causes immense suffering worldwide and is expensive for health services to treat....
International Edition